Varadha Balaji Venkadakrishnan/LinkedIn
Aug 27, 2025, 16:46
Varadha Balaji Venkadakrishnan: PROX1 – A Key Driver of Neuroendocrine Prostate Cancer
Varadha Balaji Venkadakrishnan, Instructor at Dana-Farber Cancer Institute, Instructor in Medicine at Harvard Medical School, shared a post on X about a paper he co-authored with colleagues published in Cancer Research:
“Excited to share our new study in Cancer Research!
We focus on PROX1 as a key driver of neuroendocrine Prostate Cancer and highlight its potential as a therapeutic target.
Huge thanks to Misha Beltran for her mentorship!”
Title: Epigenetic De-repression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression
Authors: Varadha Balaji Venkadakrishnan, Adam Presser, Nathaniel C. E. Voss, James Neiswender, Lisa Brenan, Keira Prenza. Sosa, Kenny Weng, Andres M. Acosta, Francisca Vazquez, Himisha Beltran
You can read the Full Article on Cancer Research.
More posts featuring Varadha Balaji Venkadakrishnan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 27, 2025, 16:34
Aug 27, 2025, 16:00
Aug 27, 2025, 15:55
Aug 27, 2025, 15:53
Aug 27, 2025, 15:52
Aug 27, 2025, 15:51
Aug 27, 2025, 15:38